Changeflow GovPing Healthcare & Life Sciences Patent Application: Methods for Reducing Blood ...
Routine Notice Added Draft

Patent Application: Methods for Reducing Blood Lipids Using Plants and Spices

Favicon for changeflow.com USPTO Patent Applications - Therapeutics (A61P)
Published
Detected
Email

Summary

The USPTO has published a new patent application (US20260083802A1) detailing methods and compositions for reducing blood lipids using plants and spices, specifically Dichrostachys glomerata or Cissus quadrangularis. The application was filed on September 26, 2024.

Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

This document is a published patent application from the USPTO, not a regulatory rule or guidance. It describes methods and compositions for reducing blood lipids in mammals using specific plant extracts, Dichrostachys glomerata and Cissus quadrangularis. The application, filed on September 26, 2024, outlines potential health benefits including increased GLP-1 levels and reduced visceral fat, food intake, blood lipids, total cholesterol, and total glucose.

As this is a patent application, it does not impose direct regulatory obligations or compliance deadlines on entities. However, it signals potential future developments in therapeutic areas related to lipid management and may be of interest to pharmaceutical and biotechnology companies for research and development purposes. Compliance officers in these sectors should be aware of emerging intellectual property in this space.

Archived snapshot

Mar 26, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

METHODS AND COMPOSITIONS FOR REDUCING BLOOD LIPIDS IN A MAMMAL USING NATURALLY OCCURING PLANTS AND SPICES

Application US20260083802A1 Kind: A1 Mar 26, 2026

Inventors

Shil Kothari, Julius Enyoug Oben

Abstract

Methods and compositions using Dichrostachys glomerata or Cissus quadrangularis separately to provide a variety of health benefits, including but not limited to, increase GLP-1 levels and reduce or decrease visceral fat, food intake, blood lipids, total cholesterol and total glucose in a mammal. In one embodiment, a composition for reducing blood lipids in a mammal is provided where the composition comprises an effective amount of Dichrostachys glomerata provided as an oral dosage unit in the form of a pill, capsule, liquid, lozenge or tablet.

CPC Classifications

A61K 36/48 A61P 3/06 A61K 2236/17 A61K 2236/33

Filing Date

2024-09-26

Application No.

18898614

View original document →

Named provisions

Inventors Abstract CPC Classifications Filing Date Application No.

Get daily alerts for USPTO Patent Applications - Therapeutics (A61P)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
September 26th, 2024
Instrument
Notice
Legal weight
Non-binding
Stage
Draft
Change scope
Minor
Document ID
US20260083802A1

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing 3254.1 Biotechnology
Activity scope
Drug Development Therapeutic Research
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Topics
Food Safety Healthcare

Get alerts for this source

We'll email you when USPTO Patent Applications - Therapeutics (A61P) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!